Seroatlas · Human Serome Atlas

PIGO

GPI ethanolamine phosphate transferase 3, catalytic subunit

Also known as: DKFZp434M222, FLJ00135, PIGO_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8TEQ8
Gene
PIGO
Ensembl
ENSG00000165282
Chromosome
9
Canonical length
1089 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
Subcellular location
Nucleoplasm,Nucleoli

OverviewNCBI Gene

This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid which contains three mannose molecules in its core backbone. The GPI-anchor is found on many blood cells and serves to anchor proteins to the cell surface. This protein is involved in the transfer of ethanolaminephosphate (EtNP) to the third mannose in GPI. At least three alternatively spliced transcripts encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]

Canonical amino-acid sequenceUniProt

1089 residues, UniProt reviewed canonical sequence.

>Q8TEQ8|PIGO
     1  MQKASVLLFL AWVCFLFYAG IALFTSGFLL TRLELTNHSS CQEPPGPGSL PWGSQGKPGA
    61  CWMASRFSRV VLVLIDALRF DFAQPQHSHV PREPPVSLPF LGKLSSLQRI LEIQPHHARL
   121  YRSQVDPPTT TMQRLKALTT GSLPTFIDAG SNFASHAIVE DNLIKQLTSA GRRVVFMGDD
   181  TWKDLFPGAF SKAFFFPSFN VRDLDTVDNG ILEHLYPTMD SGEWDVLIAH FLGVDHCGHK
   241  HGPHHPEMAK KLSQMDQVIQ GLVERLENDT LLVVAGDHGM TTNGDHGGDS ELEVSAALFL
   301  YSPTAVFPST PPEEPEVIPQ VSLVPTLALL LGLPIPFGNI GEVMAELFSG GEDSQPHSSA
   361  LAQASALHLN AQQVSRFLHT YSAATQDLQA KELHQLQNLF SKASADYQWL LQSPKGAEAT
   421  LPTVIAELQQ FLRGARAMCI ESWARFSLVR MAGGTALLAA SCFICLLASQ WAISPGFPFC
   481  PLLLTPVAWG LVGAIAYAGL LGTIELKLDL VLLGAVAAVS SFLPFLWKAW AGWGSKRPLA
   541  TLFPIPGPVL LLLLFRLAVF FSDSFVVAEA RATPFLLGSF ILLLVVQLHW EGQLLPPKLL
   601  TMPRLGTSAT TNPPRHNGAY ALRLGIGLLL CTRLAGLFHR CPEETPVCHS SPWLSPLASM
   661  VGGRAKNLWY GACVAALVAL LAAVRLWLRR YGNLKSPEPP MLFVRWGLPL MALGTAAYWA
   721  LASGADEAPP RLRVLVSGAS MVLPRAVAGL AASGLALLLW KPVTVLVKAG AGAPRTRTVL
   781  TPFSGPPTSQ ADLDYVVPQI YRHMQEEFRG RLERTKSQGP LTVAAYQLGS VYSAAMVTAL
   841  TLLAFPLLLL HAERISLVFL LLFLQSFLLL HLLAAGIPVT TPGPFTVPWQ AVSAWALMAT
   901  QTFYSTGHQP VFPAIHWHAA FVGFPEGHGS CTWLPALLVG ANTFASHLLF AVGCPLLLLW
   961  PFLCESQGLR KRQQPPGNEA DARVRPEEEE EPLMEMRLRD APQHFYAALL QLGLKYLFIL
  1021  GIQILACALA ASILRRHLMV WKVFAPKFIF EAVGFIVSSV GLLLGIALVM RVDGAVSSWF
  1081  RQLFLAQQR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PIGO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
14
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
19 nTPM

Expression across tissuesHPA

Tissue

  • parathyroid gland: 19 nTPM
  • thyroid gland: 14 nTPM
  • pancreas: 14 nTPM
  • kidney: 13 nTPM
  • salivary gland: 12 nTPM
  • adrenal gland: 12 nTPM

Single-cell type

  • syncytiotrophoblasts: 29 nCPM
  • cytotrophoblasts: 27 nCPM
  • early primary spermatocytes: 27 nCPM
  • respiratory ionocytes: 23 nCPM
  • fallopian tube ciliated cells: 22 nCPM
  • extravillous trophoblasts: 21 nCPM

Immune cell

  • myeloid DC: 9.6 nTPM
  • plasmacytoid DC: 6.4 nTPM
  • eosinophil: 5.7 nTPM
  • intermediate monocyte: 5.6 nTPM
  • basophil: 5.3 nTPM
  • memory CD8 T-cell: 5.3 nTPM

Brain region

  • white matter: 11 nTPM
  • choroid plexus: 8.9 nTPM
  • cerebellum: 7.7 nTPM
  • medulla oblongata: 7.7 nTPM
  • spinal cord: 7.4 nTPM
  • basal ganglia: 6.9 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about PIGO.

Disease | AllUniProt

Conditions PIGO is implicated in, by any mechanism.

Disease | GeneticClinVar

81 pathogenic / likely-pathogenic of 1,071 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.81
gnomAD pLI
0
gnomAD missense Z
0.96
DepMap mean gene effect
-0.1
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PIGO as an antibody target. Whether an autoantibody or antibody against PIGO could matter depends on whether native PIGO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PIGO is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label PIGO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PIGO. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...